Hai Liu

Director, Biostatistics
BioMarin Pharmaceutical, Inc.

Presentation(s):

• OC 21.5 - Comparative effectiveness of valoctocogene roxaparvovec and prophylactic factor VIII replacement estimated through propensity scoring

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM